Publication | Closed Access

Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer

UrologyGenitourinary CancerTemsirolimus PharmacokineticsMedicineCancer GeneticsOncologyRadiation OncologyAbcb1 Genetic PolymorphismsMetastatic Bladder Cancer